Ophthalmic Drug Xiidra Recalled for Failed Impurity Specifications
Novartis is recalling 1,187,092 vials of Xiidra ophthalmic solution nationwide due to failed impurities and degradation specifications in specific lot numbers.
- Product
- XIIDRA — XIIDRA (LIFITEGRAST)
- Category
- Drug
- Distribution
- Distributed nationwide